Comparison of clinical outcomes of cabozantinib plus nivolumab and lenvatinib plus pembrolizumab in patients with metastatic renal cell carcinomaKazutaka Nakamura, Toshio Takagi, Hiroaki Shimmura et al.|International Urology and Nephrology|2026Cited by 0